Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1995
08/09/1995EP0665840A1 Dopamine receptor subtype ligands
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0665748A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0665747A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0665739A1 Morphogen-induced periodontal tissue regeneration
08/09/1995EP0659179A4 Benzo-fused lactams promote release of growth hormone.
08/09/1995EP0554313B1 Disubstituted aryl compounds exhibiting selective leukotriene b 4? antagonist activity
08/09/1995EP0425650B1 Anti-inflammatory 4-aminophenol derivatives
08/09/1995CN1106408A 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors 2-beta-alkenyl-penam-sulfonverbindungen als beta-lactamase-hemmer
08/09/1995CN1106405A Trisubstituted pyrimido |5,4-d¨ pyrimidines for modulating
08/09/1995CN1106401A Novel macrolides and the use thereof
08/09/1995CN1106398A Esculetin derivatives, process for manufacture and use thereof, and pharmaceutical composition
08/09/1995CN1106397A Condensed cyclic compounds and their use
08/09/1995CN1106388A 1,2-dihydro-2-oxo-pyridine
08/09/1995CN1106387A 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine
08/09/1995CN1106381A Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same
08/09/1995CN1106368A Triterpene derivatives and endothelin-receptor antagonists containing the same
08/09/1995CN1106264A Oyster extract and method for preparing its prepn.
08/09/1995CN1106260A Methods for inhibiting cartilage degradation
08/08/1995US5440046 Angiotensin antagonist, hypotensive agent
08/08/1995US5440035 Leukotriene antagonists; antiallergens, antiinflammatory agents
08/08/1995US5439937 Antiinflammatory agent
08/08/1995US5439929 Bicyclic carbamates, pharmaceutical compositions and use
08/08/1995US5439922 Piperidyl-substituted indoles for treating anxiety
08/08/1995US5439918 Inhibitors of farnesyl-protein transferase
08/08/1995US5439909 2-Substituted with amide or thioamide group; antioxidant for lipoproteins, antilipemic agents, anticholesterol agents
08/08/1995US5439895 4-aminoquinazoline derivatives
08/08/1995US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production
08/08/1995CA1336597C Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
08/08/1995CA1336581C Aloe composition and uses thereof
08/03/1995WO1995020597A1 Modified oligonucleotides
08/03/1995WO1995020588A1 Indole derivatives as 5-ht1 agonists
08/03/1995WO1995020587A1 Neuroprotective chroman compounds
08/03/1995WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995WO1995020579A1 Cyanoguanidines as k-channel blockers
08/03/1995WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
08/03/1995WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995WO1995020571A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
08/03/1995WO1995020568A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
08/03/1995WO1995020564A1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020563A1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020396A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995WO1995020395A1 Atopic disease remedy
08/03/1995WO1995020386A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
08/03/1995WO1995012660A3 Recombinant p53 adenovirus methods and compositions
08/03/1995WO1995004720A3 Gastrin and cck receptor ligands
08/03/1995CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995CA2182219A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995CA2182198A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
08/03/1995CA2181475A1 Indole derivatives as 5-ht1 agonists
08/03/1995CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995CA2180727A1 Modified oligonucleotides
08/03/1995CA2180528A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995CA2179036A1 Cyanoguanidines as k-channel blockers
08/02/1995EP0665227A1 Polyhydronorharman synthase inhibitors
08/02/1995EP0665015A2 Combination treatment for osteoporosis
08/02/1995EP0665003A1 The use of a spin acceptor in a cosmetic on dermatological composition
08/02/1995EP0664808A1 Imidazopyridine derivatives as 5-ht 4? receptor antagonists
08/02/1995EP0664806A1 Heterocyclic condensed benzoic acid derivatives as 5-ht 4? receptor antagonists
08/02/1995EP0664805A1 Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists
08/02/1995EP0664804A1 Benzofuran derivatives as 5-ht1-like receptor antagonists
08/02/1995EP0664801A1 Amide derivatives
08/02/1995EP0664789A1 Inhibitors of farnesyl protein transferase
08/02/1995EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
08/02/1995EP0664711A1 Peptide inhibitors of cellular adhesion
08/02/1995EP0664706A1 Protein kinase c inhibition and novel compound balanol
08/02/1995EP0664700A1 Treatment of cachexia and inhibition of il-6 activity
08/02/1995EP0664697A1 Ranitidine chewable tablets
08/02/1995EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
08/02/1995CN1106005A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives
08/02/1995CN1106004A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
08/02/1995CN1105998A Naphthoxazines
08/02/1995CN1105993A Preparation of sustituted azole
08/02/1995CN1105991A Quinoline compounds
08/02/1995CN1105988A 1-amino-ethylindole-derivatives
08/02/1995CN1105984A Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
08/02/1995CN1105882A Parathyroid hormone and raloxifene for increasing bone mass
08/02/1995CN1105858A Pyrimidones and imidazolinones for treatment of shock
08/02/1995CN1105853A Methods for inhibiting bone loss
08/02/1995CN1029403C 2-oxo-1-oxa-8-azaspiro|4,5¨ decane derivatives, pharmaceutical compositions containing them and process for preparing-same
08/01/1995US5438151 Reacting N-alpha, N-alpha dimethylated histidine ester salt with halogenothionoformate in presence of base to obtain sulfur containing substituent, protecting, reacting with alkylating agent, freeing by saponification or hydrolysis
08/01/1995US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists
08/01/1995US5438118 Peptide mimics having constrained peptide backbone
08/01/1995US5438067 Medetomidine preparations for transdermal administration
08/01/1995US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders
08/01/1995US5438048 Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation
08/01/1995US5437863 Administering interleukin-11,-6, leukemia inhibitory factor, oncostatin M or ciliary neurotrophic factor; regeneration of intestines, stomach, skin, hair sperm and liver cells; chemo- or radiation therapy
08/01/1995CA2141231A1 6-azaindole thromboxane synthase inhibitors
08/01/1995CA2140953A1 Polyhydronorharman synthase inhibitors
08/01/1995CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines
08/01/1995CA1336506C Method for protection from chemotherapeutic side effects
08/01/1995CA1336505C L-carnitine enriched pet food
07/1995
07/29/1995CA2140952A1 Combination treatment for osteoporosis
07/27/1995WO1995019989A1 PORE FORMING PEPTIDES FROM $i(GEOLYCOSA RIOGRANDE)
07/27/1995WO1995019985A1 Haemopoietic maturation factor
07/27/1995WO1995019978A1 Tetracyclic derivatives, process of preparation and use
1 ... 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 ... 1564